A human-relevant alternative infection model for mucormycosis using the silkworm Bombyx mori
PLOS One · 25.09.2025 · 20 (9) · e0333476
DOI: 10.1371/journal.pone.0333476 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 25.09.2025. Verfasst von Masaki Ishii und 4 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute of Pharmaceutical Sciences, Faculty of Pharmacy, Musashino University, Tokyo, Japan. Hauptthemen laut MEDLINE: Bombyx, Mucormycosis, Disease Models, Animal, Mucorales. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Teikyo University Team Resarch Grant, Bio-oriented Technology Research Advancement Institution.
Abstract (Originalsprache)
Mucorales fungi cause life-threatening mucormycosis in patients with clinical risk factors, such as immunodeficiency. Moreover, they are resistant to several antifungal drugs, highlighting the urgent need for novel therapies. Traditional mammalian models are expensive and raise ethical concerns, thereby limiting their suitability for large-scale studies. We established a silkworm ( Bombyx mori ) infection model to investigate the pathogenicity of Mucorales and evaluated its relevance to human infection. Strains of Rhizopus arrhizus , Mucor circinelloides , and Cunninghamella bertholletiae induced fatal infections in the silkworm. Grocott-stained silkworm tissue sections revealed hyphal invasion patterns closely resembling those observed in human mucormycosis. In addition, experimental simulation of clinical risk factors (steroid use and iron overload) significantly reduced the median lethal dose (LD 50 ). Treatment with the antifungal drug isavuconazonium prolonged the survival of R. arrhizus -infected silkworms, suggesting the potential use of this model for novel antifungal screening. LD 50 estimation for four R. arrhizus strains revealed up to a 100-fold difference in pathogenicity to the silkworm among the tested strains, corresponding to variations in cell surface characteristics. Interestingly, the presence of high-molecular weight (50–100 kDa) cell surface proteins was associated with high pathogenicity among R. arrhizus strains. In conclusion, the silkworm is a viable, human-relevant alternative model to investigate Mucorales infections, with potential for large-scale antimucormycosis drug screening.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Research Institute of Pharmaceutical Sciences, Faculty of Pharmacy, Musashino University, Tokyo, Japan.
- Institute of Medical Mycology, Teikyo University, Tokyo, Japan.
- Graduate School of Medical Care and Technology, Teikyo University, Tokyo, Japan.
- Department of Health and Dietetics, Faculty of Health and Medical Science, Teikyo Heisei University, Tokyo, Japan.
ORCID-Profile: Masaki Ishii
Förderung
- Japan Society for the Promotion of Science
- Teikyo University Team Resarch Grant
- Bio-oriented Technology Research Advancement Institution
Zitieren
APA
Ishii, M., Mikami, K., Tabuchi, F., Maruyama, N., & Miyashita, A. (2025). A human-relevant alternative infection model for mucormycosis using the silkworm Bombyx mori. PLOS One, 20(9), e0333476. https://doi.org/10.1371/journal.pone.0333476
Vancouver
Ishii M, Mikami K, Tabuchi F, Maruyama N, Miyashita A. A human-relevant alternative infection model for mucormycosis using the silkworm Bombyx mori. PLOS One. 2025;20(9):e0333476. doi:10.1371/journal.pone.0333476
BibTeX
@article{Ishii2025,
author = {Ishii, Masaki and Mikami, Kazuhiro and Tabuchi, Fumiaki and Maruyama, Naho and Miyashita, Atsushi},
title = {A human-relevant alternative infection model for mucormycosis using the silkworm Bombyx mori},
journal = {PLOS One},
year = {2025},
volume = {20},
number = {9},
pages = {e0333476},
doi = {10.1371/journal.pone.0333476}
}
EUVIMED